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Abstract
Background: Stereotactic-Radio-Surgery (SRS) using Conformal-Arc-Therapy (CAT) is a well established irradiation
technique for treatment of intracranial targets. Although small safety margins are required because of very high
accuracy of patient positioning and exact online localisation, there are still disadvantages like long treatment time,
high number of monitor units (MU) and covering of noncircular targets. This planning study analysed whether
Rapid Arc (RA) with stereotactic localisation for single-fraction SRS can solve these problems.
Methods: Ten consecutive patients were treated with Linac-based SRS. Eight patients had one or more brain
metastases. The other patients presented a symptomatic vestibularis schwannoma and an atypic meningeoma. For
all patients, two plans (CAT/RA) were calculated and analysed.
Results: Conformity was higher for RA with additional larger low-dose areas. Furthermore, RA reduced the number
of MU and the treatment time for all patients. Dose to organs at risk were equal or slightly higher using RA in
comparison to CAT.
Conclusions: RA provides a new alternative for single-fraction SRS irradiation combining advantages of short
treatment time with lower number of MU and better conformity in addition to accuracy of stereotactic localisation
in selected cases with uncomplicated clinical realization.
Background
Stereotactic Radiosurgery (SRS) using Conformal Arc
Therapy (CAT) is a well established and commonly
used irradiation technique for applying high dose to the
target while sparing dose to surrounding critical struc-
tures via steep dose gradient outside the lesion [1,2].
A very high accuracy of patient positioning and exact
online localisation during treatment is required to
diminish the safety margin between gross tumour
volume (GTV) and planning target volume (PTV). How-
ever, there are still some disadvantages like long treat-
ment time, a large number of monitor units (MU), and
difficulties in covering of noncircular or ellipsoid targets.
In the past, conventional Intensity Modulated Radio-
therapy (IMRT) was tested to resolve the difficulties in
covering of noncircular or ellipsoid targets with mixed
success but without solving all described problems as
well in fractionated as in single fraction irradiation pro-
cedures [3-7].
In the next step, Rapid Arc (RA) - as an advanced
development of IMRT - was explored effectually for
hypo-fractionated irradiation of brain metastases or
benign intracranial diseases [8-10]. The RA technology
delivers an entire IMRT treatment in a single gantry
rotation around the patient. Three dynamic parameters
can be continuously varied to create IMRT dose distri-
butions: The speed of rotation, beam shaping aperture,
and delivery dose rate [11]. The variation of these three
dynamic parameters is used to cover the planning target
volume with clinical acceptable dose and to minimise
the dose to organs at risk (OAR) and normal tissue.
Because of the volumetric single arc, treatment time is
very short compared to IMRT or CAT including excel-
lent target covering, especially for complex and irregular
lesions. For example, Clivio et al. [12] found that RA
showed improvements in lowering the dose to the OAR
and healthy tissue with uncompromised target coverage
in irradiation of patients with anal cancer. In contrast,
the volume of low dose areas of the normal tissue is
higher in RA delivery, and should be considered for * Correspondence: hendrik.wolff@med.uni-goettingen.de
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patients.
However, RA has been evaluated for application of
hypo-fractionated radiotherapy but not for single frac-
tion radiosurgery, yet. A treatment composed of single
fraction RA irradiation with stereotactic localisation
could possibly unify advantages of both treatment tech-
niques with accuracy of radiosurgery, shorter treatment
time, and better coverage of targets in selected cases.
Thus, aim of the present study was to compare quality
criteria of both techniques for ten patients with different
intracranial targets with special reference to feasibility,
critical structures, and target covering.
Patients and Methods
Ten consecutive patients with macroscopic intracranial
tumours were treated with Linac based SRS at our
department from 11/2008 to 10/2009. Two patients
were women, eight patients were men, and the median
age was 61.4 years (range 44 to 76 years). Eight patients
received irradiation because of one or more intracranial
metastases of a primary peripheral tumour. Five of these
presented 1 solitary, two 2 and one patient 4 brain
metastases, which were included into one treatment tar-
get volume (GTV) for treatment planning and later ana-
lysis. One patient showed a symptomatic vestibularis
schwannoma on the left side, and another patient was
treated because of an atypic meningeoma in the left area
of the clivus. Each patient was reviewed by a radiation
oncologist and neuroradiologist before SRS to verify
treatment eligibility. The presented consecutive 10 cases
showed varieties in number of isocenters, shape, volume
and distances to critical structures and were consciously
selected to evaluate positive and negative factors for
both treatment modality options (patient and lesion
characteristics are summarized in table 1). All proce-
dures were followed in accordance with the ethical
standards of the responsible committee on human
experimentation and with Helsinki Declaration of 1975,
as revised in 2000.
Treatment planning
Lesions of each patient were evaluated on a 1.5 mm
slice magnetic resonance imaging (MRI) scan with con-
trast medium (Gadolinium). For Conformal Arc plan-
ning, image data set was transferred to the planning
workstation where the responsible radiation oncologist
(same person H.A.W. for all ten cases with expertise in
SRS) manually outlined the target volume and OAR on
axial images using FastPlan (version 5.5.1, Varian Medi-
c a lS y s t e m s ,P a l oA l t o ,C A ,U S A ) .T h eG T Vf o rC A T
was defined using the contrast-enhancing T1 weighted
MRI. The GTV should, as commonly recommended, be
covered with either the 80% isodose line for one isocen-
ter or the 70% isodose line for two or more isocenters
to minimize the maximum dose inside the GTV due to
the overlapping of two or more round treatment fields
outlined with the cones. To accomplish optimal target
covering different cone-widths from 5 mm to 25 mm
were tested during planning procedure for each isocen-
ter to achieve best results. No additional expansion of
the target volume was added. If one patient had two or
more targets, all separate targets were combined to one
GTV for posterior plan evaluation. Multiple arcs (differ-
ent numbers and angles of beams) were designed to
take the best advantage of decreasing the dose to OAR’s
and normal brain tissue.
In the next step, a high resolution computer tomogra-
phy (CT) scan with 3 mm slices was performed with
SOMATOM Balance (Siemens Medical Systems, For-
chheim, Germany). For this examination, a customized
bite block for later localisation during treatment proce-
dure was prepared and patients were fixed on treatment
couch with an individual thermoplastic mask.
Table 1 Patient characteristics
Pat.
no
Gender Age
(years)
Diagnosis Summated
GTV (cm
3)
Number of
isocenters
Prescribed SRS
dose (Gy)
Prescription isodose
CAT/RA (%)
Distance to nearest
OAR (cm)
1 M 58 1 metastasis 0.1 1 11.0 80/95 3.7
2 M 76 Vestibularis
schwannoma
0.9 2 13.0 70/95 0.6
3 F 44 2 metastases 0.3 2 22.0 80/95 4.2
4 M 55 1 metastasis 8.4 1 18.0 80/95 1.2
5 M 61 1 metastasis 3.2 1 18.0 80/95 2.8
6 M 60 1 metastasis 0.1 1 24.0 80/95 3.4
7 F 64 1 metastasis 0.7 1 24.0 80/95 4.0
8 M 72 Atypic
meningeoma
2.7 1 14.0 70/95 2.8
9 F 64 4 metastases 2.0 4 22.0 80/95 3.5
10 M 60 2 metastases 0.3 2 24.0 80/95 3.6
F: female, M: Male, GTV: Gross Tumour Volume, SRS: Stereotactic Radiosurgery, CAT: Conformal Arc Technique, RA: Rapid Arc, OAR: organ at risk.
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sagittal reconstructions for MRI-CT fusion of both data
sets was carried out to match the target volume on MRI
scan with the localisation system using CT scan by the
software FastPlan (see above).
Dose concept for each patient was assessed individu-
ally dependent on tumour entity, tumour volume and
involved critical structures: Metastases were irradiated
with a dose between 11 Gy and 24 Gy, whereas the
patient with vestibularis schwannoma received a dose of
13 Gy. Dose concept for one patient with atypic menin-
geoma was calculated to 14 Gy. Photon energy was
assessed to 6 MV for all plans.
For each patient another treatment plan using RA was
calculated on the same CT/MRI scan. All RA plans
were designed using a progressive resolution algorithm
(PRO, version 8.2.23, Varian, Medical Systems, Helsinki,
Finland). The dose distribution was calculated using the
anisotropic analytical algorithm with a grid size of 0.2
cm × 0.2 cm × 0.2 cm (AAA, version 8.2.23, Varian
Medical System, Helsinki, Finland). The AAA is a 3D
pencil beam convolution/superposition algorithm that
uses separate Monte Carlo derived modelling for pri-
mary photons, scattered extra-focal photons, and elec-
trons scattered from the beam limiting devices [13,14].
The single arc treatment field was split in 177 control
points. The modulation was achieved by delivering 177
control points. For each control point, the beam aper-
ture as defined by Millennium 120 multi leaf collimator
(MLC) (Varian Medical Systems, Palo Alto, CA, USA)
changed with the gantry angle to deliver the intensity
modulated dose to the patient. The dose rate was varied
between 0 MU/min to a maximum of 800 MU/min and
the gantry rotation between 0.0°/sec and a maximum of
about 4.8°/sec. To minimise the contribution of tongue
and groove effect during the treatment the collimator
was rotated to 45°. All plans were generated using the
Eclipse planning system (Version 8.5, Varian Medical
Systems, Helsinki, Finland). The quality assurance of
R a p i dA r ct r e a t m e n tf i e l d sw a sc o n d u c t e dw i t ht h e
“I’mRT-MatriXX” (Scanditronix, Wellhöfer, Schwarzen-
bruck, Germany) and the Software: “OmniPro I’mRT”
(version 1.5, Scanditronix, Wellhöfer, Schwarzenbruck,
Germany). Only in one patient a full rotation was neces-
sary to cover the GTV.
The GTV had to be covered by the 95% isodose line.
According to the ICRU 50 report [15] the maximum
dose should not exceed 107% of the prescribed dose.
Organs at risk including the brainstem, chiasm, optical
nerves, healthy brain and lenses were contoured manu-
ally on each single MRT slice for dose-volume-histo-
gram (DVH) analysis. The dose to OAR was aimed to
be as low as possible.
Stereotactic Radiosurgery Treatment Procedure
All patients received single session Linac based SRS.
Therefore, the patients were placed supine on the treat-
ment couch as before during CT scan. In the next step,
the previously constructed thermoplastic mask and the
bite block with reflecting fiducials was attached to the
patient. Patient position was registered by the reflecting
fiducials and an in room camera system. The camera
system was verified before patient setup. Due to the ver-
ification process the camera system saves the position of
the linac based isocenter in the treatment room. The
information about the treatment plan based isocenter
was send to the camera system. The camera system dis-
played the shift between the isocenter defined by the
bite block fiducials and the treatment plan based isocen-
ter. After the alignment of both isocenters the patient is
positioned exactly to the treatment plan based isocenter.
The irradiation took place at a Varian 2300 C/D Clinac
(Varian Medical Systems, Palo Alto, CA, USA) with fix
cones for CAT. For RA treatment the patients can be
localized within the isocenter via the same in room
camera system before single arc irradiation.
Dosimetric evaluation parameters and statistical analysis
Each treatment plan was evaluated with regard to target
c o v e r a g e ,d o s et oO A R ,t r e a t m e n tt i m e ,n u m b e ro fM U
and irradiated normal tissue. PTV conformity index (CI)
was reviewed according to the technique dependent
standard constrains including commonly valid prescrip-
tion doses for each technique as follows: For CAT plans,
ratio of target volume covered by the 80% isodose line
f o ro n ei s o c e n t e ro rt h e7 0 %i s o d o s el i n ef o rt w oo r
more isocenters divided by the total volume covered by
that isodose line was calculated. For all RA plans the
ratio of target volume covered by the 95% isodose line
divided by the total volume covered by that isodose line
was measured as usually recommended. The volume of
the body irradiated with 2 Gy was calculated to assess
low dose areas. The mean dose (Dmean) to the healthy
brain and the maximum dose (Dmax,OAR)t oO A Ra n d
GTV were calculated and dosimetric results were com-
pared for both irradiation techniques. The maximum
dose (Dmax,GTV)w a sd e f i n e da st h em a x i m u md o s e
value measured within the target volume. Analyses of
inhomogeneity indices were not performed in detail
because of intended incomparable results through the
generated GTV for SRS using CAT with 70% or 80%
isodose line for target covering with a Dmax,GTV up to
140% of the prescribed dose in comparison to maximum
dose of 107% using RA according to ICRU report [15].
Because of these established, technique dependent con-
strains RA homogeneity indices were clearly better and
would afford no reasonable information.
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GTV coverage and conformity
Mean volume of GTV was 0.8 cm
3,m e d i a n1 . 7 8c m
3,
minimum 0.1 cm
3 and maximum 8.4 cm
3.A l t h o u g h
conflicts existed in some plans resulting from the posi-
tion of OAR’s relative to the target volume (table 1),
GTV coverage was 100% in both different treatment
techniques for all patients. Thus, there was no need to
crop dose to the GTVs, even for central target localisa-
tions like vestibularis schwannomas with small distance
to the chiasm, brainstem or optical nerves.
Conformity indices were clearly better for RA in all
analysed GTV localisation and treatment volumes with
am e d i a no f0 . 5 6c o m p a r e dt o0 . 3 7f o rC A T( f i g u r e1 ) .
Especially, irregularly formed tumours were framed
more precise with the prescribed dose including less
normal tissue or OAR in high dose area. Largest
improvement was achieved in patient 1 with a factor of
2.94 (RA: 0.50; CAT: 0.17).
Although inhomogeneity index was not be analysed rea-
sonable in detail (see above), the Dmax of GTV was reduced
dramatically for all patients using RA (19.9 Gy vs. 24.4 Gy).
Dose to organs at risk and normal tissue
In general, the dose to OAR is very low. However, in 7
of 10 analysed patients RA achieved a better dose pre-
servation of OAR in general comparison of all involved
tissues. Only patient 3, 4 and 8 showed a predominantly
better result for CAT (table 2). Two of these patients
had peripheral brain metastases with a large distance to
central OAR like brainstem, optical nerves or lenses
(patients 3 and 4). The other patient, treated because of
an atypic meningeoma in the area of the clivus, could
be irradiated with constant lower doses at all OAR
because of the steeper dose gradient using CAT. Patient
associated dose distributions of both techniques were
illustrated in (figure 2).
The Dmean of the healthy brain tissue was lower using
RA in all patients. In contrast, low-dose areas could be
kept clearly smaller using CAT in all cases (table 2). In
maximum, low-dose volume was up to 12.5 times smal-
ler using CAT for treatment of 2 peripheral brain
metastases in patient 3 compared to RA.
Field Setup, Treatment Time and Monitor Units
The number of arcs using CAT depended on the num-
ber of required isocenters, whereas for RA single isocen-
ter planning was used. Patients with one isocenter were
treated with 5 arcs in conformal therapy, whereas
patients with two isocenters received 10 to 12 arcs.
Additionally, patient 9 with four different isocenters was
irradiated with 20 arcs. Treatment time for delivering
prescribed dose was definitely longer in all CAT cases
compared to single RA treatment (median time: 34.4
min vs. 4.5 min). Especially, for irradiation of patients
with more than one isocenter, treatment time was ≥ 17
times longer using CAT (patients 2 and 3) (figure 3).
Furthermore, median number of MU was 6504 MU
for CAT and 3455 MU for RA. In patient 6 with single
peripheral metastasis the number of MU was nearly the
same for both techniques (4618 MU (CAT) vs. 4663
MU (RA)), whereas for patient 4 CAT needed only 2964
MU compared to 3577 MU for RA for one single per-
ipheral metastases. In all other cases, RA got along with
obvious less number of MU (figure 4).
Discussion
Our data show promising results analysing and imple-
menting a new approach for delivering single fraction
radiosurgery via RA with additional advantages in com-
parison to standard Conformal Arc application accuracy.
Similar results for IMRT were shown before by Baumert
et al. 2003 [16] by analyzing intensity modulated radio-
therapy compared to conformal static arc therapy in
treatment of meningioma of the skull base. In this work,
IMRT was superior in PTV coverage with lower doses
to the OAR admittedly in fractionated therapy regime,
too. In another work from Wu et al. [6], results for
treatment of intracranial lesions using IMRT were clas-
sified as superior to a 3D-conformal static technique
and dynamic conformal arcs concerning dosimetric ben-
efits for SRS. However, these studies showed positive
results even without including the new benefits evolving
through tested RA. In this context, Clark et al. [8] evalu-
ated the relative plan quality of single-isocenter vs.
multi-isocenter radiosurgical treatment of multiple cen-
tral nervous system metastases for VMAT irradiation. In
this planning study, plans were created using VMAT for
treatment of simulated patients with three brain metas-
tases. They concluded that radiosurgery for multiple tar-
gets using a single isocenter can be efficiently delivered,
requiring less than one-half the beam time required for
multiple isocenter set ups, too. In their opinion, VMAT
Figure 1 Diagram of Conformity Index for CAT (Conformal Arc
Therapy) in black and for RA (Rapid Arc) in white
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ques for linear accelerator-based treatment of multiple
targets in the future. Furthermore, Lagerwaard et al.
[10] used RA to plan and deliver whole-brain radiother-
apy (WBRT) with a simultaneous integrated boost in
patients with multiple brain metastases. In this study,
RA plans showed excellent coverage of planning target
volume for WBRT and PTV for the boost. These result
led the authors to the conclusion that RA treatment
planning and delivery of integrated plans of WBRT and
boosts to multiple brain metastases is a rapid and accu-
rate technique that has a higher conformity index than
conventional summation of WBRT and radiosurgery
boost.
In comparison, our conformity results were also better
for RA because of merely ellipsoid target shaping in
CAT using cones with circular fields. Because of this
fact, high-dose volumes could be kept significantly smal-
ler with RA. In contrast, low-dose volume was clearly
smaller using CAT in all patients. This fact could be
expected because of rotation around the patient with
continuous beam on time using RA with 177 control
points compared to step and shoot irradiation using
CAT with 5 to 20 arcs. Furthermore, the distance
between beam shaping aperture and patient is higher for
RA. For CAT, the cones minimise the distance between
beam shaping aperture and patient and therefore gener-
ate steeper dose gradients. This result may play no
Table 2 Summary of Organs at risk
Patient No. 1 2 3 4 5 6 7 8 9 10
Technique CAT RA CAT RA CAT RA CAT RA CAT RA CAT RA CAT RA CAT RA CAT RA CAT RA
Healthy brain
Dmean [Gy]
0.1 0.3 0.4 0.5 0.6 3 1.0 1.4 2.1 5.2 0.3 0.6 0.6 0.7 0.6 1 1.3 3.2 0.5 2.2
V2Gy [cm
3] 8.6 53 59.5 104.8 68.7 860.3 316.8 394.4 92.3 145.7 37.6 99.9 100.8 105.7 99.6 367.6 223.7 1057 71.4 601
OAR Dmax [Gy]
Lens left 0.0 0.5 0.0 0.1 0.1 1.3 0.0 1.3 0.6 0.1 0.3 0.2 0.0 0.0 0.0 1.9 0.6 0.3 0.3 0.6
Lens right 0.0 0.4 0.0 0.1 0.0 1.4 1.1 2.5 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.3 0.3 0.6
Brainstem 0.4 1.5 3.7 6.9 0.5 7.1 2.3 3.4 0.8 0.7 0.5 0.8 0.9 0.1 4.9 4.9 2.0 1.2 0.9 2.1
Chiasm 0.0 0.9 0.5 3.8 0.1 3.8 0.7 2.5 0.6 0.0 0.0 0.4 0.0 0.1 1.2 4.2 1.4 1.7 0.0 1.7
N. opticus right 0.0 0.6 0.0 0.2 0.2 3.2 2.4 1.4 0.7 0.1 0.0 0.3 0.0 0.0 0.3 2.6 0.5 1.0 0.4 1.3
N. opticus left 0.0 0.9 0.5 0.3 0.2 3.7 0.0 0.9 0.8 0.1 0.5 0.3 0.0 0.0 1.2 4.6 1.4 1.0 0.5 1.4
Healthy brain (Dmean), low-dose volume (V2G y ) for all patients and both treatment techniques. The maximum dose to OAR is shown in Gy, the mean dose to
healthy brain in Gy, and the low dose volume (volume which is irradiated with maximum of 2 Gy) in cm
3.
OAR = organs at risk, CAT = conformal arc therapy, RA = Rapid Arc, Dmean = mean dose, V2G y= volume irradiated with 2 Gy or higher, Fat marked fields indicate
a benefit for this value.
Figure 2 Comparison of representative dose distributions for conformal arc (left) and RapidArc (right) illustrating typical differences
between both techniques in patient 8 treated because of an atypic meningeoma in the area of the clivus.
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situation. However, whenever younger patients with
longer estimated lifetime were analysed for irradiation,
risk of development of a secondary tumour should be
more weighted for final choice of treatment technique.
Especially, patient with benign disease should be ana-
lysed very carefully according to this complexity of pro-
blems (for example dose distribution of patient 2 with a
vestibularis schwannoma is illustrated in figure 5).
Higher cumulative dose in GTV as result of CAT can
be subordinated in treatment for malignant diseases like
metastases, but should be considered for irradiation of
benign targets, too. Whenever OARs are involved in
high dose areas risk of impairment with irreparable
damage rises [17-20]. For example, treatment of vestibu-
laris schwannoma involves the N. acousticus directly
into the target volume. In this case higher cumulative
doses using CAT should be considered. Similar results
were achieved from Lagerwaard et al. 2009 [9]. In their
work, RA irradiation for vestibular schwannomas was
compared to conformal arc therapy. In conclusion, they
found a better conformity and lower cumulative doses
with equal dose exposure to the OAR and significant
shorter treatment time for RA, too. These results had
led to RA replacing CAT for vestibular schwannomas in
their department.
In our study, treatment time was clearly shorter using
RA for all patients. This fact results from fewer patient
positioning procedures (1 time for RA; 1 time for every
single arc using CAT) and single arc irradiation techni-
que compared to several single arc using CAT. When-
ever patient constitution allows no long recumbency,
this parameter should be considered very carefully for
choice of technique and could afford an important bene-
fit for RA.
In this context, number of MU was clearly lower for
RA in 8 of 10 patients. This item could be an advantage
for patients because of less scattered radiation and for
the daily routine of the department because of better
time utilisation of the accelerators.
Interestingly, size of target GTV had no clearly impact
on treatment choice in our patient population. For
example, patients 1, 6 and 10 had a small GTV with a
maximum of 0.3 cm
3 and were considered for RA treat-
ment, whereas patient 3 with a GTV of 0.3 cm
3 was
selected for CAT. In addition, in patients with larger
GTVs (patients 4, 5, 8) no definitely benefit for one
technique could be observed.
Doses at OAR were generally very low. Thus, this
parameter should not be overestimated for technique
selection but should be kept in mind especially for
patients with exposure due to pre-irradiation of the
brain or head. In these cases sparing of dose at OAR
could be very important to avoid serious side effects
during irradiation or in follow-up.
Comparing results of all parameters, choice of treat-
ment techniques could be reclassified retrospectively in
selected cases: patients 1, 5, 6, 7 and 9 achieved compar-
able dose exposure to the OAR for all measured para-
meters for both treatment techniques. Dose maximum,
treatment time and number of MU showed clearly bet-
ter results for RA. Solely, irradiated low dose volume
was lower in patients 1, 5, 6 and 9 for CAT. Because of
palliative indication, these five patients would have been
treated with RA with much shorter treatment time and
comparable OAR sparing, in future.
Patient 2 was irradiated because of a vestibularis
schwannoma. In this case, dose to the brain stem and
chiasm was higher using RA (figure 5). Furthermore,
benign indication of irradiation increased the impor-
tance of the fact that involved low dose volume for RA
was nearly twice as much as for CAT. An eventually
higher risk of tumour induction by low dose irradiation
areas [21-23] and higher OAR doses led to a final deci-
sion for CAT, although treatment time and number of
MU were higher.
Analyzing patient 3 with two peripheral metastases led
in a clear decision for CAT. The dose to all OAR, low
Figure 3 Diagram of Treatment Time for CAT (Conformal Arc
Therapy) in black and for RA (Rapid Arc) in white. The
treatment time does not include the setup of patient and setup
between every single arc for CAT. The displayed treatment time is
the time where the beam is on.
Figure 4 Diagram of calculated Monitor Units (MU) for CAT
(Conformal Arc Therapy) in black and RA (Rapid Arc) in white.
The MU for each single arc using CAT were summed up and
displayed. For RA only one arc was used.
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clearly better results for CAT. Merely, treatment time
and number of MU would argue for RA but were rea-
sonable for this patient using CAT.
For patient 8 CAT would be the treatment of choice,
as well. Dose to the OAR and low dose volume were
assessed as clear benefit for CAT, even though treat-
ment time and number of MU were better using RA.
Results of patient 4 showed comparable results for
both techniques. On the one hand, dose to OAR was
slightly better using CAT for 4 of 6 items (table 2), but
on the other hand, treatment time and dose maximum
were better for RA. In the palliative situation of this
patient, both choices of treatment technique should be
arguable without any major disadvantages for this
patient.
Analyses of patient 10 showed a retrospective decision
in aid of RA. Shorter treatment time with less number
of MU preponderated a slightly lower dose to the brain
stem and chiasm as well as smaller low dose volume by
use of CAT.
In summary, the choice of treatment technique should
be done with respect to target entity, dimension and
localisation as well as patient age and constitution. It is
recommended to evaluate both techniques prior to
treatment decision.
Conclusion
We conclude that RA is a new approach for single frac-
tion radiosurgery treatment. In selected cases, RA com-
bines advantages of short treatment time with less
number of MU and better conformity in addition to
accuracy of stereotactic localisation, but with larger low
dose areas in comparison to conventional cone based
SRS. For this reason we successfully integrated this new
approach into our treatment routine and started to
irradiate patients with promising results.
Nevertheless, irradiation with CAT is not dispensable
at the moment, but should rather kept in mind to be
another feasible approach with different advantages for
selected settings.
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